Macrogenics (MGNX) Change in Cash (2012 - 2026)
Macrogenics (MGNX) reported Change in Cash of $9.3 million for Q1 2026, up 124.95% year-over-year from $4.1 million in Q1 2025, and up 140.59% quarter-over-quarter from -$22.9 million in Q4 2025.
Macrogenics (MGNX) Change in Cash (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Change in Cash data on file, last reported at $9.3 million in Q1 2026.
- Change in Cash for Q1 2026 came in at $9.3 million, up 124.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$79.1 million (down 221.22% YoY), and the FY2025 annual result was -$125.6 million, down 253.42% from the prior year.
- Change in Cash advanced to $9.3 million in Q1 2026 per MGNX's latest filing, from -$22.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $115.4 million in Q1 2023 and troughed at -$115.5 million in Q2 2023.
- A 5-year average of -$3.4 million and a median of -$14.9 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash surged 3905.38% in 2022, then slumped 812.66% in 2025.
- A 5-year view of Change in Cash shows it stood at $24.9 million in 2022, then plunged by 55.57% to $11.1 million in 2023, then tumbled by 70.93% to $3.2 million in 2024, then tumbled by 812.66% to -$22.9 million in 2025, then jumped by 140.59% to $9.3 million in 2026.
- Business Quant data shows MGNX's Change in Cash at $9.3 million in Q1 2026, -$22.9 million in Q4 2025, and -$50.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.30 Mn |
| Dec 31, 2025 | -22.91 Mn |
| Sep 30, 2025 | -50.56 Mn |
| Jun 30, 2025 | -14.88 Mn |
| Mar 31, 2025 | -37.27 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 95.69 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | -20.60 Mn |
| Dec 31, 2023 | 11.06 Mn |
| Sep 30, 2023 | -18.86 Mn |
| Jun 30, 2023 | -115.51 Mn |
| Mar 31, 2023 | 115.38 Mn |
| Dec 31, 2022 | 24.89 Mn |
| Sep 30, 2022 | 62.52 Mn |
| Jun 30, 2022 | -25.86 Mn |
| Mar 31, 2022 | -76.14 Mn |
| Dec 31, 2021 | -67.06 Mn |
| Sep 30, 2021 | 1.56 Mn |
| Jun 30, 2021 | -29.53 Mn |